PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset
Presentation Product Chemical substance Chapter Items dispensed
Canesten Combi Pessary & Cream
0702020F0BBANAK
Canesten (Vaginal) Clotrimazole Obstetrics, Gynaecology and Urinary-Tract Disorders 237
Flotros 20mg tablets
0704020Z0BCAAAA
Flotros Trospium chloride Obstetrics, Gynaecology and Urinary-Tract Disorders 237
Tamurex 400microgram modified-release capsules
0704010U0BSAAAA
Tamurex Tamsulosin hydrochloride Obstetrics, Gynaecology and Urinary-Tract Disorders 235
Alprostadil 20microgram inj cartridges
0704050B0AAAVAV
Alprostadil (Impotence) Alprostadil Obstetrics, Gynaecology and Urinary-Tract Disorders 234
Levosert 20micrograms/24hours intrauterine device
0703023L0BDAAAA
Levosert Levonorgestrel Obstetrics, Gynaecology and Urinary-Tract Disorders 230
Gyno-Pevaryl 1% cream
0702020H0BCACAA
Gyno-Pevaryl Econazole nitrate Obstetrics, Gynaecology and Urinary-Tract Disorders 219
Sodium citrate 4g oral powder sachets
0704030J0AAAHAH
Sodium citrate (Systemic) Sodium citrate Obstetrics, Gynaecology and Urinary-Tract Disorders 210
Sodium citrate 4g granules for oral solution sachets
0704030J0AAAIAI
Sodium citrate (Systemic) Sodium citrate Obstetrics, Gynaecology and Urinary-Tract Disorders 209
Katya 30/75 tablets
0703010F0BMAAAE
Katya Combined ethinylestradiol 30mcg Obstetrics, Gynaecology and Urinary-Tract Disorders 207
Tamsulosin 400micrograms/5ml oral solution
0704010U0AAACAC
Tamsulosin hydrochloride Tamsulosin hydrochloride Obstetrics, Gynaecology and Urinary-Tract Disorders 191
Canesten Thrush Combi 500mg Soft Gel pess & External 2% crm
0702020F0BBATAK
Canesten (Vaginal) Clotrimazole Obstetrics, Gynaecology and Urinary-Tract Disorders 189
Ethinylestradiol 35microgram / Norethisterone 1mg tablets
0703010G0AAABAB
Combined ethinylestradiol 35mcg Combined ethinylestradiol 35mcg Obstetrics, Gynaecology and Urinary-Tract Disorders 189
Tolterodine 2mg/5ml oral suspension
0704020N0AAAJAJ
Tolterodine Tolterodine Obstetrics, Gynaecology and Urinary-Tract Disorders 182
Lovima 75microgram tablets
0703021Q0BKAAAA
Lovima Desogestrel Obstetrics, Gynaecology and Urinary-Tract Disorders 181
Tamsulosin 400micrograms/5ml oral suspension
0704010U0AAAFAF
Tamsulosin hydrochloride Tamsulosin hydrochloride Obstetrics, Gynaecology and Urinary-Tract Disorders 172
Alprostadil 10microgram inj cartridges
0704050B0AAAWAW
Alprostadil (Impotence) Alprostadil Obstetrics, Gynaecology and Urinary-Tract Disorders 170
Ambelina 150microgram/30microgram tablets
0703010F0CLAAAC
Ambelina Combined ethinylestradiol 30mcg Obstetrics, Gynaecology and Urinary-Tract Disorders 169
Propiverine 45mg modified-release capsules
0704020P0AAADAD
Propiverine hydrochloride Propiverine hydrochloride Obstetrics, Gynaecology and Urinary-Tract Disorders 167
Petyme 400microgram MR capsules
0704010U0BHAAAA
Petyme Tamsulosin hydrochloride Obstetrics, Gynaecology and Urinary-Tract Disorders 164
Emselex 15mg modified-release tablets
0704020ACBBABAB
Emselex Darifenacin hydrobromide Obstetrics, Gynaecology and Urinary-Tract Disorders 157
Nystatin 100,000unit pessaries
0702020T0AAAFAF
Nystatin (Vaginal) Nystatin Obstetrics, Gynaecology and Urinary-Tract Disorders 144
Norinyl-1 tablets
0703010M0BBAAAA
Norinyl-1 Combined mestranol Obstetrics, Gynaecology and Urinary-Tract Disorders 137
Synphase tablets (Pfizer)
0703010P0BEAAAF
Synphase Phased formulations of ethinylestradiol Obstetrics, Gynaecology and Urinary-Tract Disorders 136
Contiflo XL 400microgram capsules (NorthStar)
0704010U0BMABAA
Contiflo Tamsulosin hydrochloride Obstetrics, Gynaecology and Urinary-Tract Disorders 130
Emselex 7.5mg modified-release tablets
0704020ACBBAAAA
Emselex Darifenacin hydrobromide Obstetrics, Gynaecology and Urinary-Tract Disorders 130

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.